enGene Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $87.0M
Liabilities Breakdown FY2023
Total Liabilities: $14.5M
Asset Breakdown
Total Assets: $87.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $81.5M | 93.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $589.0K | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.8M | 5.6% |
Liabilities Breakdown
Total Liabilities: $14.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 8.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $13.3M | 92.0% |